While lack of OPRM1 causes ALL cell resistance to asparaginase (Kang et al., 2017), the fact that PKA inhibition can circumvent the upsteam OPRM1-AC-cAMP step suggests that PKA may be targeted for therapy in L-asparaginase-resistant ALL. Here, OPRM1 is linked to acute lymphoblastic leukemia.